Journal of Medicinal Chemistry p. 7422 - 7444 (2020)
Update date:2022-08-15
Topics:
Bonardi, Alessandro
Nocentini, Alessio
Bua, Silvia
Combs, Jacob
Lomelino, Carrie
Andring, Jacob
Lucarini, Laura
Sgambellone, Silvia
Masini, Emanuela
McKenna, Robert
Gratteri, Paola
Supuran, Claudiu T.
The "tail approach"has become a milestone in human carbonic anhydrase inhibitor (hCAI) design for various therapeutics, including antiglaucoma agents. Besides the classical hydrophobic/hydrophilic division of hCAs active site, several subpockets have been
View MoreChangde Yungang Biotechnology Co., Ltd
website:http://www.cdyg.com
Contact:+86-736-7391178
Address:Qiaonan Industrial Park, Changde City, Hunan Province
Liaoning Yufeng Chemical Co.,Ltd.
Contact:86-0419-3418888
Address:The metallurgical industrial zone,shoushan town, Liaoyang, Liaoning, China
Nantong Kaixin Pharma Chemical Co.,Ltd.
Contact:86-513-85250786
Address:2-1103 Huachen Mansion, 111 Gongnong Road,Nantong, Jiangsu, China
Xi'an Costrong Pharmaceutical Co., Ltd.
Contact:029- 68576496
Address:Room 2004,Shuibao Building,No.190,South Erhuan Rd, Yanta District,Xi'an,Shaan Xi,China
Shanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Doi:10.1016/j.tetlet.2006.01.031
(2006)Doi:10.1016/j.bmcl.2005.03.069
(2005)Doi:10.1021/ja057352w
(2006)Doi:10.1002/ejic.200500678
(2005)Doi:10.1002/anie.200503028
(2006)Doi:10.1021/ja01185a026
(1948)